The Journal of Urology
Volume 184, Issue 3 , Pages 938-943 , September 2010

[11C]Choline Positron Emission Tomography/Computerized Tomography to Restage Prostate Cancer Cases With Biochemical Failure After Radical Prostatectomy and No Disease Evidence on Conventional Imaging

  • Giampiero Giovacchini

      Affiliations

    • Center for Molecular Bioimaging, University of Milano-Bicocca, Milan, Italy
    • ,
  • Maria Picchio

      Affiliations

    • Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy
    • Corresponding Author InformationCorrespondence: Department of Nuclear Medicine, San Raffaele Scientific Institute, Via Olgettina, 66, 20132 Milan, Italy (telephone: +39-02-2643-5456; FAX: +39-02-2643-3817)
    • ,
  • Alberto Briganti

      Affiliations

    • Department of Urology, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Cesare Cozzarini

      Affiliations

    • Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Vincenzo Scattoni

      Affiliations

    • Department of Urology, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Andrea Salonia

      Affiliations

    • Department of Urology, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Claudio Landoni

      Affiliations

    • Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Luigi Gianolli

      Affiliations

    • Department of Nuclear Medicine, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Nadia Di Muzio

      Affiliations

    • Department of Radiation Oncology, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Patrizio Rigatti

      Affiliations

    • Department of Urology, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Francesco Montorsi

      Affiliations

    • Department of Urology, San Raffaele Scientific Institute, Milan, Italy
    • ,
  • Cristina Messa

      Affiliations

    • Center for Molecular Bioimaging, University of Milano-Bicocca, Milan, Italy
    • Institute for Bioimaging and Molecular Physiology, National Research Council, Milan, Italy
    • Department of Nuclear Medicine, San Gerardo Hospital, Monza, Italy

Received 15 December 2009

References 

  1. Pound CR, Partin AW, Eisenberger MA, et al. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591
  2. Price DT, Coleman RE, Liao RP, et al. Comparison of [18F]fluorocholine and [18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol. 2002;168:273
  3. de Jong IJ, Pruim J, Elsinga PH, et al. [11C]choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol. 2003;44:32
  4. Picchio M, Messa C, Landoni C, et al. Value of [11C]choline-positron emission tomography for re-staging prostate cancer: a comparison with [18F]fluorodeoxyglucose-positron emission tomography. J Urol. 2003;169:1337
  5. Heinisch M, Dirisamer A, Loidl W, et al. Positron emission tomography/computed tomography with F-18-fluorocholine for restaging of prostate cancer patients: meaningful at PSA < 5 ng/ml?. Mol Imaging Biol. 2006;8:43
  6. Rinnab L, Blumstein NM, Mottaghy FM, et al. (11)C-choline positron-emission tomography/computed tomography and transrectal ultrasonography for staging localized prostate cancer. BJU Int. 2007;99:1421
  7. Krause BJ, Souvatzoglou M, Tuncel M, et al. The detection rate of [(11)C]Choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35:18
  8. Reske SN, Blumstein NM, Glatting G. [(11)C]choline PET/CT imaging in occult local relapse of prostate cancer after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2008;35:9
  9. Castellucci P, Fuccio C, Nanni C, et al. Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. J Nucl Med. 2009;50:1394
  10. Giovacchini G, Picchio M, Coradeschi E, et al. Predictive factors of [(11)C]choline PET/CT in patients with biochemical failure after radical prostatectomy. Eur J Nucl Med Mol Imaging. 2010;37:301
  11. Scattoni V, Picchio M, Suardi N, et al. Detection of lymph-node metastases with integrated [11C]choline PET/CT in patients with PSA failure after radical retropubic prostatectomy: results confirmed by open pelvic-retroperitoneal lymphadenectomy. Eur Urol. 2007;52:423
  12. Oyama N, Ponde DE, Dence C, et al. Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation. J Nucl Med. 2004;45:519
  13. Scher HI, Eisenberger M, D'Amico AV, et al. Eligibility and outcomes reporting guidelines for clinical trials for patients in the state of a rising prostate-specific antigen: recommendations from the Prostate-Specific Antigen Working Group. J Clin Oncol. 2004;22:537
  14. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med. 1998;39:990
  15. Arlen PM, Bianco F, Dahut WL, et al. Prostate Specific Antigen Working Group guidelines on prostate specific antigen doubling time. J Urol. 2008;179:2181
  16. Tiguert R, Gheiler EL, Tefilli MV, et al. Lymph node size does not correlate with the presence of prostate cancer metastasis. Urology. 1999;53:367
  17. Cher ML, Bianco FJ, Lam JS, et al. Limited role of radionuclide bone scintigraphy in patients with prostate specific antigen elevations after radical prostatectomy. J Urol. 1998;160:1387
  18. Heidenreich A, Aus G, Bolla M, et al. EAU guidelines on prostate cancer. Eur Urol. 2008;53:68
  19. Partin AW, Pearson JD, Landis PK, et al. Evaluation of serum prostate-specific antigen velocity after radical prostatectomy to distinguish local recurrence from distant metastases. Urology. 1994;43:649
  20. Dotan ZA, Bianco FJ, Rabbani F, et al. Pattern of prostate-specific antigen (PSA) failure dictates the probability of a positive bone scan in patients with an increasing PSA after radical prostatectomy. J Clin Oncol. 2005;23:1962
  21. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999;17:1499
  22. Leventis AK, Shariat SF, Slawin KM. Local recurrence after radical prostatectomy: correlation of US features with prostatic fossa biopsy findings. Radiology. 2001;219:432
  23. Soloway MS, Hardeman SW, Hickey D, et al. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan. Cancer. 1988;61:195
  24. Schmid DT, John H, Zweifel R, et al. Fluorocholine PET/CT in patients with prostate cancer: initial experience. Radiology. 2005;235:623
  25. Vees H, Buchegger F, Albrecht S, et al. (18)F-choline and/or (11)C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/ml) after radical prostatectomy. BJU Int. 2007;99:1415
  26. Husarik DB, Miralbell R, Dubs M, et al. Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer. Eur J Nucl Med Mol Imaging. 2008;35:253
  27. Roehl KA, Han M, Ramos CG, et al. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol. 2004;172:910
  28. Schilling D, Schlemmer HP, Wagner PH, et al. Histological verification of 11C-choline-positron emission/computed tomography-positive lymph nodes in patients with biochemical failure after treatment for localized prostate cancer. BJU Int. 2008;102:446
  29. Schiavina R, Scattoni V, Castellucci P, et al. 11C-choline positron emission tomography/computerized tomography for preoperative lymph-node staging in intermediate-risk and high-risk prostate cancer: comparison with clinical staging nomograms. Eur Urol. 2008;54:392
  30. Roscigno M, Cozzarini C, Scattoni V, et al. A reappraisal of the role of vesicourethral anastomosis biopsy in patient candidates for salvage radiation therapy after radical prostatectomy. Radiother Oncol. 2007;82:30

 Study received approval from the Scientific Institute, San Raffaele Hospital ethical committee.

 For another article on a related topic see page 1211.

PII: S0022-5347(10)03519-6

doi: 10.1016/j.juro.2010.04.084

The Journal of Urology
Volume 184, Issue 3 , Pages 938-943 , September 2010

Article Tools

* Image Usage & Resolution